FDA approves new melanoma drug from Bristol-Myers
WASHINGTON - The Food and Drug Administration has approved a new drug from Bristol-Myers Squibb to treat the deadliest form of skin cancer.
The agency approved Opdivo for patients with hard-to-treat melanoma that cannot be removed through surgery or has spread throughout the body. The approval was based on preliminary studies showing the drug helped shrink tumors in some patients.
About 76,100 people in the U.S. will be diagnosed with melanoma this year and 9,710 people are expected to die from the disease.
Melanoma long has been considered one of the toughest cancers to treat, with few drug options up until a few years ago. Since 2011, the FDA has approved seven new drugs for the skin cancer, including Opdivo.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Livingston Parish gathering info on June storm damage
Deputy: Theriot admitted to killing 5 in 'pure, cold blood'
Used car quits, buyer takes car lot to court
Officials: 63 arrests made across Louisiana in child exploitation crackdown
Sheriff warns of bears roaming neighborhoods in St. Mary Parish